Description:
Diagnostic test products have never been more critical. Kalorama Information’s report, 2021 IVD Market Update and COVID-19 Impact, provides an updated analysis of the in vitro diagnostics (IVD) market, reflecting the latest information from our analysts. This comprehensive report includes market sizing for various IVD categories and examines the major trends and impacts of COVID-19 on the market in 2021.
Key Features of the Report:
This in-depth report offers essential data and insights for marketers and business planners, including:
- Market Sizing by Category:
- Clinical Chemistry
- Immunoassays – Non-isotopic
- Infectious Disease
- Other Immunos
- Blood Bank Screening
- Drugs of Abuse
- Diabetes HbA1c – Lab
- Hematology – Core Lab
- Microbiology (ID/AST)
- Microbiology (Molecular)
- Microbiology – Mass Spectrometry
- Radioimmunoassays
- Coagulation (PT/INR)
- Coagulation, Molecular
- Histology/Cytology
- HPV, Molecular
- Nucleic Acid Assays
- Blood Grouping/Typing
- Blood Bank Molecular
- NAT Blood Screens
- Circulating Tumor Cells
- POC, OTC Diabetes
- POC, OTC Other
- POC, Professional/Hospital
- COVID-19
COVID-19 Impact Analysis:
- Market Segment Effects:
- Detailed analysis of the effects of COVID-19 on various market segments.
- Table 1-3: IVD Market excluding and with COVID-19, 2020
- Figure 1-1: IVD Market Distribution by Segment
- Table 1-4: Global In Vitro Diagnostic Market – YoY Growth 2019-2020
- Figure 1-2: Global In Vitro Diagnostic Market – YoY Growth 2019-2020
- Figure 1-3: IVD Segment Performance, Q1 2020 – Q4 2020
- Figure 1-4: IVD Segment Performance, Total Market Value, 2020
Additional Insights:
- Product Trends and Developments: Exploration of the latest trends and developments in the IVD market.
- COVID-19 Developments: Coverage of COVID-19 related developments from September 2020 to February 2021.
- Market Participant Developments: Updates on select IVD market participants and their competitive positioning.
- Competitive Leader Updates: Analysis of leading companies in the IVD market.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Global In Vitro Diagnostic Sales, by Product Market, 2020 ($ million)
| Product Market | 2020 | %Mkt |
| Clinical Chemistry | $XX Million | XX% |
| Immunoassays- non isotopic | $XX Million | XX% |
| Infectious disease | $XX Million | XX% |
| Other immunos | $XX Million | XX% |
| Blood bank screening | $XX Million | XX% |
| Drugs of Abuse | $XX Million | XX% |
| Diabetes HbA1c, lab | $XX Million | XX% |
| Hematology – Core Lab | $XX Million | XX% |
| Microbiology (ID/AST) | $XX Million | XX% |
| Microbiology (molecular) | $XX Million | XX% |
| Microbiology – Mass Spectrometry | $XX Million | XX% |
| Radioimmunoassays | $XX Million | XX% |
| Coagulation (PT/INR) | $XX Million | XX% |
| Coagulation, molecular | $XX Million | XX% |
| d-dimer | $XX Million | XX% |
| Histology/cytology | $XX Million | XX% |
| HPV, molecular | $XX Million | XX% |
| Nucleic acid assays/genetic tests | $XX Million | XX% |
| Blood grouping/typing | $XX Million | XX% |
| Blood bank molecular – NAT Screens | $XX Million | XX% |
| Circulating tumor cells | $XX Million | XX% |
| POC, OTC diabetes | $XX Million | XX% |
| POC, OTC other | $XX Million | XX% |
| POC, professional/hospital | $XX Million | XX% |
| Mass Spectrometry | $XX Million | XX% |
| IVD Market Total | $XX Million | XX% |
Source: Kalorama Information
